admin
Cipla has completed the transfer of its generics business #39;as a going concern on a slump sale basis to Cipla Pharma and Life Sciences Limited#39;, the company told bourses
Warren Buffett may have cut Berkshire’s stake in Apple again in the third quarter
Top Wall Street analysts suggest these 3 dividend stocks for enhanced total returns
Impactive Capital sees a structural shift creating upside for this wastewater company
Exxon in advanced talks to power AI data centers with natural gas and carbon capture
Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments
This San Francisco-based satellite company’s stock has doubled in the past three months
Ray Dalio says a risky AI market bubble is forming, but may not pop until the Fed tightens
AI is driving huge productivity gains for large companies, while small companies get left behind